Ulrik B. Nielsen, Ph.D. is co-founder and CEO of Tidal Therapeutics – a Sanofi Company. Ulrik serves on the boards of Alloy, Merrimack, Unikum, and Notch Therapeutics. He was previously co-founder and CEO of Torque Therapeutics (now Repertoire Immune Medicines), executive chairman of Notch Therapeutics, and co-founder and CSO of Merrimack. Ulrik trained at University of California, San Francisco and MIT, and holds a Ph.D. in molecular biology from the University of Copenhagen.
Track Chair: Sharon Benzeno, Adaptive Biotechnologies